Polymorphisms Within RYR3 Gene Are Associated with Risk and Age at Onset of Hypertension, Diabetes, and Alzheimer's Disease
Background: Hypertension affects 33% of Americans while type 2 diabetes and Alzheimer's disease (AD) affect 10% of Americans, respectively. Ryanodine receptor 3 gene (RYR3) codes for the RYR which functions to release stored endoplasmic reticulum calcium ions (Ca2+) to increase intracellular Ca2+ concentration. Increasing studies demonstrate that altered levels of intracellular Ca2+ affect cardiac contraction, insulin secretion, and neurodegeneration. In this study, we investigated associations of the RYR3 genetic variants with hypertension, AD, and diabetes. Methods: Family data sets were used to explore association of RYR3 polymorphisms with risk and age at onset (AAO) of hypertension, diabetes, and AD. Results: Family-based association tests using generalized estimating equations (FBAT-GEE) showed several unique or shared disease-1 associated variants in the RYR3 gene. Three single nuclear polymorphisms (SNPs; rs2033610, rs2596164, and rs2278317) are significantly associated with risk for hypertension, diabetes, and AD. Two SNPs (rs4780174 and rs7498093) are significantly associated with AAO of the 3 diseases. Conclusions: RYR3 variants are associated with hypertension, diabetes, and AD. Replication of these results of this gene in these 3 complex traits may help to better understand the genetic basis of calcium-signaling gene, RYR3 in association with risk and AAO of these diseases.
Gong, Shaoqing; Su, Brenda Bin; Tovar, Hugo; Mao, Chunxiang; Gonzalez, Valeria; Liu, Ying; Lu, Yongke; Wang, Ke Sheng; and Xu, Chun. 2018. Polymorphisms Within RYR3 Gene Are Associated with Risk and Age at Onset of Hypertension, Diabetes, and Alzheimer's Disease. American Journal of Hypertension. Vol.31(7). 818-826. https://doi.org/10.1093/ajh/hpy046 PMID: 29590321 ISSN: 0895-7061